- Home
- Automated
- List of product information
- NIZORAL CREAM 2% [SIN01117P]
NIZORAL CREAM 2% [SIN01117P]
Active ingredients: NIZORAL CREAM 2%
Product Info
NIZORAL CREAM 2%
[SIN01117P]
Product information
Active Ingredient and Strength | KETOCONAZOLE - 20 MG/G |
Dosage Form | CREAM |
Manufacturer and Country | JANSSEN PHARMACEUTICA NV - BELGIUM |
Registration Number | SIN01117P |
Licence Holder | JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD |
Forensic Classification | GENERAL SALE LIST |
Anatomical Therapeutic Chemical (ATC) code | D01AC08 |
Indications
NIZORAL® 2% Cream is indicated for topical application in the treatment of dermatophyte infections of the skin: tinea corporis, tinea cruris, tinea manus and tinea pedis due to Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum canis and Epidermophyton floccosum, as well as in the treatment of cutaneous candidosis and tinea (pityriasis) versicolor.
NIZORAL® 2% Cream is also indicated for the treatment of seborrheic dermatitis, a skin condition associated with the presence of Malassezia furfur.
Dosage and Administration
Dosage
Cutaneous candidosis, tinea corporis, tinea cruris, tinea manus, tinea pedis and tinea (pityriasis) versicolor: it is recommended that NIZORAL® 2% Cream be applied once daily to cover the affected and immediate surrounding area.
Seborrheic dermatitis: NIZORAL® 2% Cream should be applied to the affected area once or twice daily.
The usual duration of treatment is tinea versicolor 2–3 weeks, yeast infections 2–3 weeks, tinea cruris 2–4 weeks, tinea corporis 3–4 weeks, tinea pedis 4–6 weeks.
The usual initial duration of treatment in seborrheic dermatitis is 2 to 4 weeks. Maintenance therapy is applied once or twice weekly in seborrheic dermatitis.
Treatment should be continued, until a few days after disappearance of all symptoms. The diagnosis should be reconsidered if no clinical improvement is noted after 4 weeks of treatment.
Special populations
Pediatrics
There are limited data on the use of ketoconazole 2% cream in pediatric patients.
Administration
Topical administration to the skin.
Contraindications
NIZORAL® 2% Cream is contraindicated in individuals with a known hypersensitivity to any of its ingredients.
